Context-specific functional module based drug efficacy prediction
暂无分享,去创建一个
Doheon Lee | Woochang Hwang | Jaejoon Choi | Mijin Kwon | Doheon Lee | W. Hwang | Mijin Kwon | Jaejoon Choi
[1] Carlotta Costa,et al. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1 , 2013, Proceedings of the National Academy of Sciences.
[2] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[3] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[4] Jason W Locasale,et al. Metabolic rewiring drives resistance to targeted cancer therapy , 2012, Molecular systems biology.
[5] P. Sorger,et al. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.
[6] R. Altman,et al. Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.
[7] Guanming Wu,et al. A network module-based method for identifying cancer prognostic signatures , 2012, Genome Biology.
[8] Mike Tyers,et al. BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..
[9] Tao Zeng,et al. Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[10] Stacey Price,et al. A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention , 2013, Cancer cell.
[11] A. Bauer-Mehren,et al. Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases , 2011, PloS one.
[12] J. Engelman,et al. Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer , 2013, Science Signaling.
[13] Tao Xu,et al. Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..
[14] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[15] J. Hou,et al. Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells , 2013, Cell Death and Disease.
[16] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .
[17] Julio Vera,et al. Context Sensitive Modeling of Cancer Drug Sensitivity , 2015, PloS one.
[18] Haiyi Jiang,et al. Overview of gefitinib in non-small cell lung cancer: an Asian perspective. , 2008, Japanese journal of clinical oncology.
[19] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[20] R. Sharan,et al. Network-based prediction of protein function , 2007, Molecular systems biology.
[21] Alexander E. Kel,et al. TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..
[22] Mina J Bissell,et al. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.
[23] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[24] Jose R. Caeiro Rey,et al. Raloxifene: Mechanism of Action, Effects on Bone Tissue, and Applicability in Clinical Traumatology Practice , 2009, The open orthopaedics journal.
[25] Xiaomei Quan,et al. Survey: Functional Module Detection from Protein-Protein Interaction Networks , 2014, IEEE Transactions on Knowledge and Data Engineering.
[26] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[27] Benjamin Haibe-Kains,et al. Research and applications: Comparison and validation of genomic predictors for anticancer drug sensitivity , 2013, J. Am. Medical Informatics Assoc..
[28] Sourav Bandyopadhyay,et al. Rewiring of Genetic Networks in Response to DNA Damage , 2010, Science.
[29] Margaret Warner,et al. Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.
[30] Gajendra P. S. Raghava,et al. Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients , 2014, Scientific Reports.